This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of more complex drug molecules. Its unique structure, featuring a hydroxyl group and an acetamide moiety, makes it a valuable building block for developing active pharmaceutical ingredients (APIs). It is particularly relevant in the creation of compounds targeting central nervous system disorders, such as neurodegenerative diseases or pain management therapies. Additionally, its chiral centers allow for the development of enantiomerically pure drugs, which can enhance efficacy and reduce side effects. Researchers also explore its potential in designing enzyme inhibitors due to its ability to interact with specific biological targets.